Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Equity (2022 - 2025)

Atara Biotherapeutics (ATRA) has disclosed Return on Equity for 4 consecutive years, with 3.03% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity fell 436.0% year-over-year to 3.03%, compared with a TTM value of 3.03% through Sep 2025, down 436.0%, and an annual FY2024 reading of 0.0%, up 2015.0% over the prior year.
  • Return on Equity was 3.03% for Q3 2025 at Atara Biotherapeutics, down from 2.02% in the prior quarter.
  • Across five years, Return on Equity topped out at 3.68% in Q4 2023 and bottomed at 3.03% in Q3 2025.
  • Average Return on Equity over 4 years is 0.33%, with a median of 0.07% recorded in 2023.
  • The sharpest move saw Return on Equity skyrocketed 383bps in 2024, then tumbled -436bps in 2025.
  • Year by year, Return on Equity stood at 0.0% in 2022, then skyrocketed by 620656bps to 3.68% in 2023, then tumbled by -100bps to 0.0% in 2024, then plummeted by -309748bps to 3.03% in 2025.
  • Business Quant data shows Return on Equity for ATRA at 3.03% in Q3 2025, 2.02% in Q2 2025, and 0.91% in Q1 2025.